Aberrant overexpression of TOP2A has been widely reported in multiple cancers, such as liver cancer and gastric cancer, where it is linked to aggressive tumor behavior and poor prognosis (Meng et al., 2022; Mangalaparthi et al., 2023; Mokhlesi et al., 2023). Here, TOP2A is linked to liver cancer.